LakeShore Biopharma Co., Ltd. SCHEDULE 13D/A
SCHEDULE 13D/A · Crystal Peak Investment Inc. · Filed Nov 4, 2025
Documents
- SCHEDULEprimary_doc.xml
- EX-99.10
JOINT FILING AGREEMENT DATED NOVEMBER 4, 2025 BY AND AMONG THE REPORTING PERSONS
- EX-99.12
EQUITY COMMITMENT LETTER, DATED NOVEMBER 4, 2025, BY AND BETWEEN THE SPONSOR AND PARENT
- EX-99.13
ROLLOVER AND SUPPORT AGREEMENT, DATED NOVEMBER 4, 2025, BY AND AMONG THE ROLLOVER SHAREHOLDERS AND PARENT
- EX-99.14
LIMITED GUARANTEE, DATED NOVEMBER 4, 2025, BY AND BETWEEN THE SPONSOR AND THE ISSUER
- EX-99.15
INTERIM INVESTORS AGREEMENT, DATED NOVEMBER 4, 2025, BY AND AMONG THE CONSORTIUM MEMBERS, PARENT AND MERGER SUB